Biomarker subgroup analyses of CodeBreaK 200, a phase 3 trial of sotorasib versus (vs) docetaxel in patients (pts) with pretreated <i>KRAS</i> G12C-mutated advanced non-small cell lung cancer (NSCLC)
dc.contributor.author | Skoulidis, F. | en |
dc.contributor.author | De Langen, A. | en |
dc.contributor.author | Paz-Ares, L. G. | en |
dc.contributor.author | Mountzios, G. S. | en |
dc.contributor.author | Curioni-Fontecedro, A. | en |
dc.contributor.author | Couraud, S. | en |
dc.contributor.author | Janssens, A. | en |
dc.contributor.author | Rocco, D. | en |
dc.contributor.author | Ohashi, K. | en |
dc.contributor.author | Vincent, M. D. | en |
dc.contributor.author | Kang, J. H. | en |
dc.contributor.author | Schvartsman, G. | en |
dc.contributor.author | Lindsay, Colin R | en |
dc.contributor.author | O'Byrne, K. J. | en |
dc.contributor.author | Dziadziuszko, R. | en |
dc.contributor.author | Andersen, J. A. L. | en |
dc.contributor.author | Hindoyan, A. | en |
dc.contributor.author | Wilmanski, T. | en |
dc.contributor.author | Wang, Y. | en |
dc.contributor.author | Schuler, M. H. | en |
dc.date.accessioned | 2023-10-25T08:48:37Z | |
dc.date.available | 2023-10-25T08:48:37Z | |
dc.date.issued | 2023 | en |
dc.identifier.citation | Skoulidis F, De Langen A, Paz-Ares LG, Mountzios GS, Curioni-Fontecedro A, Couraud S, et al. Biomarker subgroup analyses of CodeBreaK 200, a phase 3 trial of sotorasib versus (vs) docetaxel in patients (pts) with pretreated <i>KRAS</i> G12C-mutated advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772003679. | en |
dc.identifier.doi | 10.1200/JCO.2023.41.16_suppl.9008 | en |
dc.identifier.uri | http://hdl.handle.net/10541/626655 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1200/JCO.2023.41.16_suppl.9008 | en |
dc.title | Biomarker subgroup analyses of CodeBreaK 200, a phase 3 trial of sotorasib versus (vs) docetaxel in patients (pts) with pretreated <i>KRAS</i> G12C-mutated advanced non-small cell lung cancer (NSCLC) | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | University of Texas MD Anderson Cancer Center, Houston, TX | en |
dc.identifier.journal | Journal of Clinical Oncology | en |
dc.description.note | en] |